SCHEMBL28529095

SCHEMBL28529095

CN(C(=O)C(CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)c1cccc(N)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.41
▸ AAK1 Q2M2I8 1/20 0.40
▸ KLK5 Q9Y337 1/20 0.40
▸ CACNA1B Q00975 2/20 0.39
▸ ACE P12821 1/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ CTSS P25774 5/20 0.38
▸ CTSK P43235 4/20 0.38
▸ CTSB P07858 3/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ USP30 Q70CQ3 1/20 0.38
▸ CTSL P07711 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ REN P00797 1/20 0.37
▸ PPARG P37231 1/20 0.36
▸ PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529092 1.00 CYP2D6 (0.41) CYP2D6AAK1KLK5CACNA1BACE
SCHEMBL18428093 0.91 KLK5 (0.42) AAK1KLK5ACECTSSCTSK
SCHEMBL18472306 0.85 USP30 (0.36) CYP2D6AAK1KLK5USP30KMT2A
SCHEMBL28511519 0.83 CACNA1B (0.39) CYP2D6KLK5CACNA1BACEABCB1
SCHEMBL28511517 0.83 CACNA1B (0.39) CYP2D6KLK5CACNA1BACEABCB1
SCHEMBL28511501 0.83 MAPT (0.47) CACNA1BKMT2APPARGPPARA
SCHEMBL28511503 0.83 MAPT (0.47) CACNA1BKMT2APPARGPPARA
SCHEMBL28907024 0.79 HDAC4 (0.53) CYP2D6AAK1CACNA1BCTSSCTSK
SCHEMBL28907026 0.79 HDAC4 (0.53) CYP2D6AAK1CACNA1BCTSSCTSK
SCHEMBL22990703 0.76 HSD17B1 (0.42) ACECTSSCTSKCTSBJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026026-B Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof 夸德里加生物科学公司 2021-02-09 — — CN disclosed
Send feedback